Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




Combination Treatment Often Makes Liver Metastases Resectable
Link ID 16108
Title Combination Treatment Often Makes Liver Metastases Resectable
Url http://www.medscape.com/viewarticle/703562?src=rss
Description Combining hepatic artery infusion of floxuridine/dexamethasone with systemic oxaliplatin and irinotecan can make liver metastases from colorectal cancer resectable in about half of patients. Reuters Health Information
Category Articles > Hematology-Oncology
Keywords
Date Jun 2, 2009
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Hematology-Oncology
1. Evolving Concepts in the Management of Thrombocytopenia in Patients With Leukemia
  In this Special Report, expert hematologists review the epidemiology of thrombocytopenia in patients with leukemia and review current and investigational therapies that may help overcome this problem. Medscape Hematology-Oncology
Category:   Articles > Hematology-Oncology


2. American Association for Cancer Research (AACR) 100th Annual Meeting
  Read clinically focused news coverage of key developments from the meeting. Medscape Hematology-Oncology
Category:   Articles > Hematology-Oncology


3. Rituximab Maintenance Halves Lymphoma Relapse
  New results from the PRIMA study show benefits from rituximab maintenance therapy in patients who had responded to rituximab plus chemotherapy for induction. Medscape Medical News
Category:   Articles > Hematology-Oncology


4. First Gene Linked to Lung Cancer in Nonsmokers
  Lung cancer risk in many nonsmokers is tied to reductions in GPC5 expression. Medscape Medical News
Category:   Articles > Hematology-Oncology


5. New Treatment for Pediatric Hodgkin Lymphoma Patients Reduces Long-Term Effects
  A "dose-dense" chemotherapy provides high efficacy and excellent outcomes and reduces the cumulative doses of chemotherapy and radiation below thresholds usually associated with long-term toxicity. Medscape Medical News
Category:   Articles > Hematology-Oncology




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS